Haleon (HLN) Total Current Liabilities (2021 - 2025)

Haleon (HLN) posted Total Current Liabilities of $6.6 billion for Q4 2025, down 12.04% on a QoQ basis from $7.5 billion in Q4 2024, and down 12.04% year-over-year from $7.5 billion in Q4 2024.

Haleon (HLN) Total Current Liabilities (2021 - 2025) Analysis & Trends

Haleon's Total Current Liabilities history runs 5 years deep, the most recent figure standing at $6.6 billion for Q4 2025.

  • Quarterly Total Current Liabilities fell 12.04% year-over-year to $6.6 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.6 billion (down 12.04% YoY) and the FY2025 annual result came in at $6.5 billion, down 12.45% from the prior year.
  • Total Current Liabilities was $6.6 billion for Q4 2025 at Haleon, down from $7.5 billion in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $7.5 billion in Q4 2024 and bottomed at -$7.1 billion in Q2 2024.
  • A 5-year average of $1.5 billion and a median of $5.4 billion in 2021 frame the typical range for Total Current Liabilities.
  • Annual changes were most pronounced in 2023 — Total Current Liabilities retreated 18.02% — and 2024, when it gained 29.53%.
  • Haleon's Total Current Liabilities stood at $5.7 billion in 2021, then decreased by 10.28% to $5.1 billion in 2022, then grew by 12.35% to $5.8 billion in 2023, then climbed by 29.53% to $7.5 billion in 2024, then dropped by 12.04% to $6.6 billion in 2025.
  • Business Quant data shows HLN's Total Current Liabilities at $6.6 billion in Q4 2025, $7.5 billion in Q4 2024, and -$7.1 billion in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 6.56 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 13.53 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 2.05 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 18.06 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 599.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 13.17 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 6.81 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 831.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 1.66 Bn
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn 215.80 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 6.56 Bn
Dec 31, 2024 7.46 Bn
Jun 30, 2024 -7.10 Bn
Dec 31, 2023 5.76 Bn
Jun 30, 2023 -6.24 Bn
Dec 31, 2022 5.13 Bn
Jun 30, 2022 -5.29 Bn
Dec 31, 2021 5.71 Bn